haylaavo

J B CHEMICALS AND PHARMA

JBCHEPHARM · NSE · inactive
2,408.90
-97.10 (-3.87%)
as of 16 Jul 2026 close
Open
2,506.00
High
2,525.50
Low
2,380.00
Prev close
2,506.00
52w high
2,525.50
16 Jul 2026
52w low
1,638.50
26 Sept 2025
VWAP
2,418.56
Delivery %
66.8%
of volume
Volume 47.79 L · turnover ₹1155.88 Cr · NSE bhavcopy (official close), adjusted for splits/bonuses · history since 02 Feb 1995
Series
EQ
F&O
No
Status
Inactive since 17 Jul 2026

Source: NSE equity master · as of 16 Jul 2026

Market cap
—
P/B
—
ROE (TTM)
17.1%
ROCE 23.0%
Debt / equity
0.00
P/E (TTM)
—
P/S (TTM)
—
Revenue TTM
₹4,148 cr
Net profit TTM
₹709 cr
Net margin TTM
17.1%
OPM 26.0%
EV / EBITDA
—
Interest cover
172.0×
Revenue growth
-4.8%
latest quarter YoY
Profit growth
-30.4%
latest quarter YoY
Dividend yield
—
₹22 / share · payout —

Consolidated · last four quarters to 2026-03-31 · balance sheet 2026-03-31 · tap a tile for the formula

Daily · NSE EOD
Exchange announcements
Source: NSE corporate filings · latest Today 01:44 IST
  • 28 Jul 2023 18:42
    AGM / meeting

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on August 24, 2023

    PDF · -
  • 22 Jul 2023 10:41
    Compliance

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Loss of Share Certificates

    PDF · -
  • 14 Jul 2023 16:07
    Insider / SAST

    Tau Investment Holdings Pte. Ltd. has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

    PDF · -
  • 13 Jul 2023 16:35
    Compliance

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

    PDF · -
  • 30 Jun 2023 16:07
    Compliance

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Prior Public Notice for Equity Shareholders of the Company with regard to convening of AGM through Video Conferencing (VC)/Other Audio Visual Means (OAVM).

    PDF · -
  • 29 Jun 2023 18:20
    Compliance

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

    PDF · -
  • 23 Jun 2023 16:52
    Compliance

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Loss of Share Certificates

    PDF · -
  • 19 Jun 2023 18:00
    Compliance

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Newspaper advertisement in respect of transfer of equity shares of the Company to Investor Education and Protection Fund (IEPF).

    PDF · -
  • 12 Jun 2023 12:41
    General update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'USFDA inspection of Company s manufacturing facility T20 at Panoli, Gujarat'.

    PDF · -
  • 09 Jun 2023 18:17
    Compliance

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Loss of Share Certificates

    PDF · -
  • 08 Jun 2023 12:05
    General update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'General Update'.

    PDF · -
  • 31 May 2023 14:37
    Insider / SAST

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Allotment of 11410 Shares.

    PDF · -
  • 30 May 2023 11:55
    Analyst meet

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Transcript

    PDF · -
  • 26 May 2023 18:17
    General update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Intimation of schedule of Analysts/Institutional investors meet'.

    PDF · -
  • 26 May 2023 18:09
    Corporate action

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange that Record date for the purpose of Dividend is 17-Aug-2023.

    PDF · -
  • 25 May 2023 18:00
    Analyst meet

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Link of Recording

    PDF · -
  • 25 May 2023 15:08
    Compliance

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Newspaper cutting of extract of consolidated financial results for quarter and year ended on March 31, 2023

    PDF · -
  • 24 May 2023 23:58
    Compliance

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange about related Party Transactions For Half Year ended 31-03-2023

    PDF · -
  • 24 May 2023 16:56
    Analyst meet

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Investor Presentation

    PDF · -
  • 24 May 2023 16:43
    Business update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding a press release dated May 24, 2023, titled "Press Release".

    PDF · -
  • 24 May 2023 16:35
    Corporate action

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange that the Board of Directors at its meeting held on May 24, 2023, has considered and approved subdivision of 77377584 equity shares of 2 each into 154755168 equity shares of 1 each.

    PDF · -
  • 24 May 2023 16:32
    Results

    JB Chemicals & Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended March 31, 2023.

    PDF · -
  • 24 May 2023 16:29
    Dividend

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange that Board of Directors at its meeting held on May 24, 2023, recommended Final Dividend of 9.25 per equity share.

    PDF · -
  • 23 May 2023 16:42
    Insider / SAST

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Allotment of 27890 Shares.

    PDF · -
  • 22 May 2023 17:36
    Other

    Annual Secretarial Compliance Report for the financial year ended on March 31, 2023.

    PDF · -
  • 17 May 2023 13:47
    Analyst meet

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Schedule of meet

    PDF · -
  • 13 Apr 2023 17:32
    Compliance

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

    PDF · -
  • 31 Mar 2023 16:33
    Compliance

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

    PDF · -
  • 30 Mar 2023 17:20
    Compliance

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Loss of Share Certificates

    PDF · -
  • 02 Mar 2023 16:55
    Insider / SAST

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Allotment of 4762 Shares.

    PDF · -
  • 13 Feb 2023 17:17
    Analyst meet

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Transcript

    PDF · -
  • 09 Feb 2023 21:19
    Analyst meet

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Link of Recording

    PDF · -
  • 09 Feb 2023 14:38
    Compliance

    J.B. Chemicals & Pharmaceuticals Limited has informed the Exchange about Newspaper cutting of extract of consolidated financial results for quarter ended on December 31, 2022

    PDF · -
  • 08 Feb 2023 18:58
    Compliance

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Loss of Share Certificates

    PDF · -
  • 08 Feb 2023 18:53
    Corporate action

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange that Record date for the purpose of Dividend is 18-Feb-2023.

    PDF · -
  • 08 Feb 2023 18:49
    Analyst meet

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Investor Presentation

    PDF · -
  • 08 Feb 2023 18:49
    Business update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding a press release dated February 08, 2023, titled "Press Release".

    PDF · -
  • 08 Feb 2023 18:33
    Dividend

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange that Board of Directors at its meeting held on February 08, 2023, declared Interim Dividend of 8.50 per equity share.

    PDF · -
  • 08 Feb 2023 18:32
    Results

    JB Chemicals & Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended December 31, 2022.

    PDF · -
  • 07 Feb 2023 19:53
    Insider / SAST

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Allotment of 15135 Shares.

    PDF · -
  • 01 Feb 2023 18:43
    Analyst meet

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Schedule of meet

    PDF · -
  • 10 Jan 2023 16:12
    Compliance

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

    PDF · -
  • 10 Jan 2023 15:41
    Analyst meet

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Investor Presentation

    PDF · -
  • 30 Dec 2022 12:38
    Compliance

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

    PDF · -
  • 28 Dec 2022 17:36
    Compliance

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper advertisement in respect of transfer of equity shares of the Company to Investor Education and Protection Fund (IEPF).

    PDF · -
  • 21 Dec 2022 17:45
    General update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Disclosure pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015-Updates on acquisition'.

    PDF · -
  • 20 Dec 2022 15:24
    Insider / SAST

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Allotment of 3500 Shares on exercise of Stock options pursuant to Employee Stock Option Scheme

    PDF · -
  • 14 Dec 2022 16:33
    Business update

    J. B. Chemicals & Pharmaceuticals Limited has informed the Exchange about press release dated 14-Dec-2022 titled Press Release

    PDF · -
  • 14 Dec 2022 16:27
    General update

    J.B. Chemicals & Pharmaceuticals Limited has informed the Exchange about disclosure pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

    PDF · -
  • 09 Dec 2022 09:06
    Compliance

    J. B. Chemicals & Pharmaceuticals Limited has informed the Exchange about Closure of trading window

    PDF · -
Coming next in news
Arrives in Phase 3. Nothing here is estimated or filled in — we only show data we have.
  • Results & board-meeting calendar
  • Dividend, split, AGM calendar
  • Headlines with source and timestamp
  • Two-line factual filing summaries